Oncolys Biopharma Inc. (4588)
Market Closed
10 Aug, 06:00
JPX JPX Primary 
TWSE ¥
2,849. 00
+1
+0.0351%
¥
29.17B Market Cap
- P/E Ratio
- Div Yield
692,500 Volume
- Eps
¥ 2,848
Previous Close Want to track 4588 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Oncolys Biopharma Inc. (4588) Statistics
Valuation metrics
Market Cap 29.17B
Enterprise value 68.07B
Trailing P/E (ttm) -45.01
Forward P/E -27.21
PEG ratio -1.27
Price/Sales (ttm) 2,240.48
Price/Book (mrq) 23.21
Enterprise Value/Revenue 2,151.58
Enterprise Value/EBITDA -41.02
Overview
Shares outstanding 29.28M
Float 24.02M
Shares short -
% Held by insiders 0.12%
% Held by institutions 0.07%
Average volume (10 days) 797.45K
Average volume (90 days) 1.25M
Price summary
52-Week low 601
52-Week high 3,695
Beta 1.16
50-Day moving average 2,622.69
200-Day moving average 2,535.92
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -52.5%
Operating margin -52.46%
Operational effectiveness
Return on assets -0.37%
Return on equity -0.61%
Income Statement
Revenue (ttm) 28.55M
Revenue per share (ttm) 1.08
Quarterly revenue growth (yoy) -
Gross profit (ttm) 28.55M
EBITDA -2.03B
Net income to common (ttm) -2.06B
Diluted EPS (ttm) -56.73
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.35B
Total cash per share (mrq) 120.79
Total debt (mrq) 339.24M
Total Debt/Equity (mrq) 0.2
Current ratio (mrq) 5.12%
Book value per share (mrq) 122.73
Cash Flow
Cash flow statement -2.11B
Levered free cash flow (LFCF) -2.06B
